EcoDrugPlus

Purinergic Receptor P2y1

Ensembl ID : ENSDLEG00000003575
Gene Symbol: P2RY1
3 Cross references
191 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSDLEG00000003534
Gene Symbol: P2RY12
3 Cross references
182 Possible Orthologues:

Purinergic Receptor P2y2

Ensembl ID : ENSDLEG00000002113
Gene Symbol: P2RY2
1 Cross references
200 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSDLEG00000015071
Gene Symbol: P2RY4
1 Cross references
168 Possible Orthologues:

Pyrimidinergic Receptor P2y6

Ensembl ID : ENSDLEG00000002120
Gene Symbol: P2RY6
3 Cross references
183 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSDLEG00000001254
Gene Symbol: RIPK1
3 Cross references
198 Possible Orthologues:

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSDLEG00000003717
Gene Symbol: RPTOR
1 Cross references
208 Possible Orthologues:

Renin

Ensembl ID : ENSDLEG00000005739
Gene Symbol: REN
1 Cross references
220 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSDLEG00000006403
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSDLEG00000013307
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSDLEG00000008688
Gene Symbol: RARB
3 Cross references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSDLEG00000004025
Gene Symbol: RARG
3 Cross references
451 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).